Multiplexed assays for identification of biomarkers and surrogate markers in systemic lupus erythematosus

Lupus

Volumn 13, Issue 5, 2004, Pages 304-311

  Utz, P J ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Biomarkers; Clinical trials; Multiplexed assays; SLE; Surrogate markers

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; CYTOKINE;

ARTICLE; AUTOANTIBODY PROFILING; AUTOIMMUNE DISEASE; BIOASSAY; CAPTURE ARRAY; CLINICAL RESEARCH; CLINICAL TRIAL; CYTOKINE CAPTURE ARRAY; DISEASE MARKER; ETAG ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION PROFILING; HUMAN; MULTIPLEXED ASSAY; PATIENT CARE; PATIENT MONITORING; PRIORITY JOURNAL; REVERSE PHASE SIGNALING ASSAY; SIGNALING ASSAY; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSCRIPTION PROFILING; VALIDATION PROCESS; WESTERN BLOTTING;

AUTOANTIBODIES; BIOLOGICAL MARKERS; CYTOKINES; GENE EXPRESSION PROFILING; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; TRANSCRIPTION, GENETIC;

EID: 2942754023     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203303lu1017oa     Document Type: Article

References (49)

1. Lupus Foundation of America website, http://www.lupus.org/education/ stats.html 2003. Last accessed 20 April 2004.
2. Tan E, Cohen A, Fries J et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1272-1277.
3. Russo G, Zegar C, Giordano A. Advantages and limitations of microarray technology in human cancer. Oncogene 2003; 22: 6497-6507.
4. Lock C, Hermans G, Pedotti et al. Gene microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nature Med 2002; 8: 500-508.
5. Ramanathan M, Weinstock-Guttman B, Nguyen et al. In vivo gene expression revealed by cDNA arrays: the pattern in relapsing-remitting patients compared with normal subjects. J Neuroimmunol 2001; 116: 213-219.
6. Wandinger K, Sturzebecher C, Bielekova B et al. Complex immunomodulatory effects of interferon-beta in multiple sclerosis include the upregulation of T helper 1-associated marker genes. Ann Neurol 2001; 50: 349-357.
7. Ruschpler P, Lorenz P, Eichler W et al. High CXCR3 expression in synovial mast cells associated with CXCL9 and CXCL10 expression in inflammatory synovial tissues of patients with rheumatoid arthritis. Arthritis Res Ther 2003; 5: R241-R252.
8. Gallagher J, Howlin J, McCarthy C et al. Identification of Naf1/ABIN-1 among TNF-alpha-induced expressed genes in human synoviocytes using oligonucleotide arrays. FEBS Letters 2003; 551: 8-12.
9. van der Pouw Kraan T, van Gaalen F, Huizinga T, Pieterman E, Breedveld F, Verweij C. Discovery of distinctive gene expression profiles in rheumatoid synovium using cDNA microarray technology: evidence for the existence of multiple pathways of tissue destruction and repair. Genes Immun 2003; 4: 187-196.
10. van der Pouw Kraan T, van Gaalen F, Kasperkovitz P et al. Rheumatoid arthritis is a heterogeneous disease: evidence for differences in the activation of the STAT-1 pathway between rheumatoid tissues. Arthritis Rheum 2003; 48: 2132-2145.
11. Tezak Z, Hoffman E, Lutz J et al. Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis: a novel model of pathogenesis. J Immunol 2002; 168: 4154-4163.
12. Baechler E, Batliwalla F, Karypis G et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci, USA 2003; 100: 2610-2615.
13. Bennett L, Palucka A, Arce E et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 2003; 197: 711-723.
14. Maas K, Chan S, Parker J et al. Cutting edge: molecular portrait of human autoimmune disease. J Immunol 2002; 169: 5-9.
15. Rus V, Atamas S, Shustova V et al. Expression of cytokine and chemokine related genes in peripheral blood mononuclear cells from lupus patients by cDNA array. Clin Immunol 2002; 102: 283-290.
16. Rozzo S, Allard J, Choubey D et al. Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus. Immunity 2001; 15: 435-443.
17. Crow M, Wohlgemuth J. Microarray analysis of gene expression in lupus. Arthritis Res Ther 2003; 5: 279-287.
18. Thibault D, Utz PJ. Interpreting interest in interferon alpha. Arthritis Res Ther 2003; 5: 246-248.
19. von Mühlen CA, Tan EM. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 1995; 24: 323-358.
20. Li N, Aoki V, Hans-Filho G, Rivitti E, Diaz L. The role of intramolecular epitope spreading in the pathogenesis of endemic pemphigus foliaceus (Fogo Selvagem). J Exp Med 2003; 197: 1501-1510.
21. Arbuckle M, McClain M, Rubertone M et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003; 349: 1526-1533.
22. James J, Harley J. B-cell epitope spreading in autoimmunity. Immunol Rev 1998; 164: 185-200.
23. Joos T, Schrenk M, Hopfl P et al. A microarray enzyme-linked immunosorbent assay for autoimmune diagnostics. Electrophoresis 2000; 21: 2641-2650.
24. Hueber W, Utz PJ, Steinman L, Robinson W. Autoantibody profiling for the study and treatment of autoimmune disease. Arthritis Res 2002; 4: 290-295.
25. Robinson W, Steinman L, Utz PJ. Proteomics technologies for the study of autoimmune disease. Arthritis Rheum 2002; 46: 885-893.
26. Robinson W, Steinman L, Utz PJ. Protein arrays for autoantibody profiling and fine specificity mapping. Proteomics 2003; 11: 2077-2084.
27. Robinson W, DiGennaro C, Hueber W et al. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nature Med 2002; 8: 295-301.
28. Robinson W, Fontoura P, Lee B et al. Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis. Nat Biotech 2003; 21: 1033-1039.
29. Sercarz E. Arraying autoimmunity treatment. Nature Biotech 2003; 21: 1017-1019.
30. de Vegvar H, Amara R, Steinman L, Utz PJ, Robinson H, Robinson W. Microarray profiling of antibody responses against Simian-Human Immunodeficiency Virus: postchallenge convergence of reactivities independent of host histocompatibility type and vaccine regimen. J Virol 2003; 77: 11125-11138.
31. Ghanekar S, Maecker H. Cytokine flow cytometry: multiparametric approach to immune function analysis. Cytotherapy 2003; 5: 1-6.
32. Tam S, Wiese R, Lee S, Gilmore J, Kumble K. Simultaneous analysis of eight human Th1/Th2 cytokines using microarrays. J Immunol Meth 2002; 261: 157-165.
33. Lin Y, Huang R, Cao X, Wang S, Shi Q, Huang R. Detection of multiple cytokines by protein arrays from cell lysate and tissue lysate. Clin Chem Lab Med 2003; 41: 139-145.
34. Keller K, Kalwar R, Dubois K, Crouse D, Chafin W, Kane B. Multiplexed fluorescent bead-based immunoassays for quantitation of human cytokines in serum and culture supernatants. Cytometry 2001; 45: 27-36.
35. Chan-Hui P-Y, Stephens K, Singh S. Applications of the eTag assay platform to systems biology approaches to clinical immunology studies. Clin Immunol 2004; in press.
36. Xue Q, Wainright A, Gangakhedkar S, Gibbons I. Multiplexed enzyme assays in capillary electrophoretic single-use microfluidic devices. Electrophoresis 2001; 22: 4000-4007.
37. Tsokos G, Nambiar M, Tenbrock K, Juang Y-T. Rewiring the T cell; signaling defects and novel prospects for the treatment of SLE. Trends Immunol 2003; 24: 259-263.
38. Tsokos G, Liossis S-N. Immune cell signaling defects in lupus: activation, anergy, and death. Immunol Today 1999; 20: 119-124.
39. Huck S, Le Corre R, Youinou P, Zouali M. Expression of B cell receptor associated signaling molecules in human lupus. Autoimmun 2001; 33: 213-224.
40. Enyedy E, Nambiar M, Liossis S, Dennis G, Kammer G, Tsokos G. Fc epsilon receptor type I gamma chain replaces the deficient T cell receptor zeta chain in T cells of patients with systemic lupus erythematosus. Arthritis Rheum 2001; 44: 1114-1121.
41. Liossis S, Solomou E, Dimopoulos M, Panayiotidis P, Mavrikakis M, Sfikakis P. B cell kinase lyn deficiency in patients with systemic lupus erythematosus. J Investig Med 2001; 49: 157-165.
42. Grolleau A, Kaplan M, Hanash S, Beretta L, Richardson B. Impaired translational response and increased protein kinase PKR expression in T cells from lupus patients. J Clin Invest 2000; 106: 1561-1568.
43. Kammer G. Deficient protein kinase A in systemic lupus erythematosus: a disorder of T lymphocyte signal transduction. Ann NY Acad Sci 2002; 968: 96-105.
44. Monneaux F, Muller S. Altered expression of proteins in signaling, apoptosis, and autoantigen posttranslational modifications in MRL/lpr lupus mice. Personal communication.
45. Lorenz P, Ruschpler P, Koczan D, Stiehl P, Thiesen H. From transcriptome to proteome: differentially expressed proteins identified in synovial tissue of patients suffering from rheumatoid arthritis and osteoarthritis by an initial screen with a panel of 791 antibodies. Proteomics 2003; 3: 991-1002.
46. Perez O, Nolan G. Simultaneous measurement of multiple active kinase states using polychromatic flow cytometry. Nat Biotech 2002; 20: 155-162.
47. Haab B, Dunham M, Brown P. Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biology 2001; 2: RESEARCH2004.1. http://www.genomebio.com last accessed 20 March 2004.
48. Petricoin E, Zoon K, Kohn E, Barrett J, Liotta L. Clinical proteomics: translating benchside promise into bedside reality. Nature Rev 2002; 1: 683-695.
49. Soen Y, Chen D, Kraft D, Davis M, Brown P. Detection and characterization of cellular immune responses using peptide-MHC microarrays. PLoSBio 2003; 1: E65.